Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of ischemic stroke in Han Chinese of eastern China

Journal of Biomedical Research

Volumn 25, Issue 5, 2011, Pages 319-327

  Wang, Gannan ^a   Wang, Yao ^a   Sun, Hao ^a   Cao, Weijuan ^a   Zhang, Jing ^a   Xiao, Hang ^b   Zhang, Jinsong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Arachidonate 5 lipoxygenase activating protein; Ischemic stroke; Leukotriene B4; Risk factors; Variants

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; LEUKOTRIENE B4;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BRAIN ISCHEMIA; CHINA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 80054869874     PISSN: 16748301     EISSN: 16748301     Source Type: Journal    
DOI: 10.1016/S1674-8301(11)60043-2     Document Type: Article

References (31)

1. Jia Q, Liu LP, Wang YJ Stroke in China. Clin Exp Pharmacol Physiol 2010, 37:259-264.
2. Matarin M, Singleton A, Hardy J, Meschia J The genet-ics of ischaemic stroke. J Intern Med 2010, 267:139-155.
3. Yamada Y, Ichihara S, Nishida T Proinflammatory gene polymorphisms and ischemic stroke. Curr Pharm Des 2008, 14:3590-3600.
4. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, et al. Proportion of different subtypes of stroke in China. Stroke 2003, 34:2091-2096.
5. Matarin M, Brown WM, Dena H, Britton A, De Vrieze FW, Brott TG, et al. Candidate gene polymorphisms for ischemic stroke. Stroke 2009, 40:3436-3442.
6. Lindsberg PJ, Grau AJ Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34:2518-2532.
7. Helgadottir A, Manolescu A, Thorleifsson G, Gretars-dottir S, Jonsdottir H, Thorsteinsdottir U, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36:233-239.
8. Riccioni G, Bäck M, Capra V Leukotrienes and athero-sclerosis. Curr Drug Targets 2010, 11:882-887.
9. Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005, 76:505-509.
10. Zintzaras E, Rodopoulou P, Sakellaridis N Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis. Am J Epidemiol 2009, 169:523-532.
11. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
12. Kelly TN, Gu D, Chen J, Huang JF, Chen JC, Duan X, et al. Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 2008, 39:1688-1693.
13. Shen CD, Zhang WL, Sun K, Wang YB, Zhen YS, Hui RT Interaction of genetic risk factors confers higher risk for thrombotic stroke in male Chinese: a multicenter case-control study. Ann Hum Genet 2007, 71:620-629.
14. Sun H, Wu H, Zhang J, Wang J, Lu Y, Ding H, et al. A tagging SNP in ALOX5AP and risk of stroke: a haplo-type-based analysis among eastern Chinese Han population. Mol Biol Rep 2010, 38:4731-4738.
15. Stephens M, Donnelly P A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169.
16. Lõhmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005, 36:731-736.
17. Zhang WL, Yang XM, Shi J, Sun K, Hui RT Polymor-phism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort. Yi Chuan Xue Bao (in Chinese) 2006, 33:678-684.
18. Kaushal R, Pal P, Alwell K, Haverbusch M, Flaherty M, Moomaw C, et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet 2007, 121:601-607.
19. Yamada Y, Kato K, Oguri M, Yoshida T, Yokoi K, Watanabe S, et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese indi-viduals with metabolic syndrome. Int J Mol Med 2008, 21:801-808.
20. Bevan S, Dichgans M, Wiechmann HE, Gschwendtner A, Meitinger T, Markus HS Genetic variation in mem-bers of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations. Stroke 2008, 39:1109-1114.
21. Domingues-Montanari S, Fernández-Cadenas I, del Rio-Espinola A, Corbeto N, Krug T, Manso H, et al. Asso-ciation of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study. Cerebrovasc Dis 2010, 29:528-537.
22. Meschia JF, Brott TG, Brown RD, Crook R, Worrall BB, Kissela B, et al. Phosphodiesterase 4D and 5-lipoxyge-nase activating protein in ischemic stroke. Ann Neurol 2005, 58:351-361.
23. Zee RY, Cheng S, Hegener HH, Erlich HA, Ridker PM Genetic variants of arachidonate 5-lipoxygenase-acti-vating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 2006, 37:2007-2011.
24. Lemaitre RN, Rice K, Marciante K, Bis JC, Lumley TS, Wiggins KL, et al. Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke. Atherosclerosis 2009, 204:e58-e63.
25. Kostulas K, Gretarsdottir S, Kostulas V, Manolescu A, Helgadottir A, Thorleifsson G, et al. PDE4D and ALOX5AP genetic variants and risk for ischemic cer-ebrovascular disease in Sweden. J Neurol Sci 2007, 263:113-117.
26. Lövkvist H, Smith JG, Luthman H, Höglund P, Norrving B, Kristoffersson U, et al. Ischaemic stroke in hyperten-sive patients is associated with variations in the PDE4D genome region. Eur J Hum Genet 2008, 16:1117-1125.
27. Quarta G, Stanzione R, Evangelista A, Zanda B, Di An-gelantonio E, Marchitti S, et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians. Eur J Hum Genet 2009, 17:1448-1453.
28. Markus HS, Alberts MJ Update on genetics of stroke and cerebrovascular disease 2005. Stroke 2006, 37:288-290.
29. Evans JF, Ferguson AD, Mosley RT, Hutchinson JH What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases. Trends Pharmacol Sci 2008, 29:72-78.
30. Gulcher JR, Gretarsdottir S, Helgadottir A, Stefansson K Genes contributing to risk for common forms of stroke. Trends Mol Med 2005, 11:217-224.
31. Bäck M Inhibitors of the 5-lipoxygenase pathway in atherosclerosis. Curr Pharm Des 2009, 15:3116-3132.